Wire Stories
HDT Bio, Gennova Biopharmaceuticals Announce First Healthy Volunteers Dosed in Phase I/II Trials Of Unique COVID-19 RNA Vaccine in India
HDT Bio�s RNA-based vaccine offers simpler manufacturing, easier deployment, and requires vastly lower dosing than current COVID-19 vaccines SEATTLE–(BUSINESS WIRE)–HDT Bio Corp.,...